Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study

被引:1
作者
Kidane, Biniam [1 ]
Manji, Farouq [1 ]
Lam, Jennifer [1 ]
Taylor, Brian M. [1 ]
机构
[1] Univ Western Ontario, Univ Hosp, Schulich Sch Med & Dent, Rm C8-114,339 Windermere Rd, London, ON N6A 5A5, Canada
关键词
D O I
10.1155/2016/5797804
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Surgery for GI dysmotility is limited to those with severe refractory disease. Though effective, use of serotonergic promotility drugs has been restricted in Canada due to adverse events. We aimed to investigate utilization of promotility serotonergic drugs in patients under consideration for surgical management. Methods. A retrospective cohort study was conducted using prospectively collected data. The study population included consecutive patients referred to a motility clinic for consideration of bowel resection at a Canadian tertiary hospital (1996-2011). Univariable tests and multivariable logistic regression analyses were used to assess predictors of serotonergic drug use. Results. Of 128 patients, the majority (n = 98, 76.6%) had constipation-dominant symptoms. Only 25% (n = 32) had tried serotonergic promotility drugs. There was no association between use of these drugs and severity of constipation nor was there an association between serotonergic drug use and presence of diffuse dysmotility (all p > 0.05). The majority of patients (n = 97, 75.8%) underwent some type of surgical resection, which was associated with considerable morbidity (n = 13, 13.4%). Conclusions. Surgical management of GI dysmotility results in serious morbidity. Serotonergic promotility drugs may allow patients to avoid surgery but disease severity does not predict use of these drugs.
引用
收藏
页数:5
相关论文
共 23 条
[1]   Lack of Association of Tegaserod With Adverse Cardiovascular Outcomes in a Matched Case-Control Study [J].
Anderson, Jeffrey L. ;
May, Heidi T. ;
Bair, Tami L. ;
Muhlestein, Joseph B. ;
Horne, Benjamin D. ;
Carlquist, John F. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (03) :170-175
[2]   Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surgery [J].
Beck, DE ;
Opelka, FG ;
Bailey, HR ;
Rauh, SM ;
Pashos, CL .
DISEASES OF THE COLON & RECTUM, 1999, 42 (02) :241-248
[3]   ANXIETY, PAIN, AND DEPRESSION SURROUNDING ELECTIVE SURGERY - MULTIVARIATE COMPARISON OF ABDOMINAL-SURGERY PATIENTS WITH KIDNEY DONORS AND RECIPIENTS [J].
CHAPMAN, CR ;
COX, GB .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1977, 21 (01) :7-15
[4]   Introduction. The Rome Foundation and Rome III [J].
Drossman, D. A. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (10) :783-786
[5]   Quality of life after subtotal colectomy for slow-transit constipation - Both quality and quantity count [J].
FitzHarris, GP ;
Garcia-Aguilar, J ;
Parker, SC ;
Bullard, KM ;
Madoff, RD ;
Goldberg, SM ;
Lowry, A .
DISEASES OF THE COLON & RECTUM, 2003, 46 (04) :433-440
[6]  
Health Canada, 2007, VOL SUSP SAL ZELN DU
[7]   An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome [J].
Kellow, J ;
Lee, OY ;
Chang, FY ;
Thongsawat, S ;
Mazlam, MZ ;
Yuen, H ;
Gwee, KA ;
Bak, YT ;
Jones, J ;
Wagner, A .
GUT, 2003, 52 (05) :671-676
[8]  
Kidane B, 2015, AM SURGEON, V81, P187
[9]   Outcome of colectomy for slow transit constipation [J].
Knowles, CH ;
Scott, M ;
Lunniss, PJ .
ANNALS OF SURGERY, 1999, 230 (05) :627-638
[10]   Improved Health-Related Quality of Life After Surgical Management of Severe Refractory Constipation-Dominant Irritable Bowel Syndrome [J].
Lam, Jennifer Y. ;
Kidane, Biniam ;
Manji, Farouq ;
Taylor, Brian M. .
INTERNATIONAL SURGERY, 2015, 100 (01) :63-69